A.‐M. Stalfelt

Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone

Kajsa Ideström, Eva Kimby, Magnus Björkholm et al. · European Journal of Cancer and Clinical Oncology · 1982 · 56 citations

Medicine, Hematology, Oncology +12

High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

A. Åhre, Magnus Björkholm, Anders Österborg et al. · European Journal Of Haematology · 1988 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +13

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS

Anders Österborg, A. Åhre, Magnus Björkholm et al. · European Journal Of Haematology · 1989 · 39 citations

Medicine, Oncology, Pharmacology +11

Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma

A. Åhre, Magnus Björkholm, Håkan Mellstedt et al. · European Journal of Cancer and Clinical Oncology · 1983 · 29 citations

Medicine, Hematology, Oncology +10

Treatment of multiple myeloma with interferon alpha: the Scandinavian experience

Håkan Mellstedt, Anders Österborg, Magnus Björkholm et al. · British Journal of Haematology · 1991 · 24 citations

Medicine, Hematology, Pharmacotherapy +13